膝动脉栓塞治疗膝骨关节炎中大口径导管与微导管的操作成功率和临床结局比较
回顾性分析79例膝骨关节炎患者行膝动脉栓塞,按使用微导管经大口径导管或直接经大口径导管分组。微导管组操作成功率100%,大口径导管组91%(p=0.069);大口径导管组手术和透视时间显著更短、辐射剂量明显降低;两组VAS和WOMAC评分无显著差异。
要点
- 大口径导管直接行膝动脉栓塞操作成功率91%,微导管组为100%(p=0.069)。
- 大口径导管组手术时间和透视时间显著更短(p<0.001),空气比释动能值明显降低。
- 两组1、3、6个月VAS和WOMAC评分无显著差异。
核心结论
- 在使用临时栓塞剂(亚胺培南/西司他丁)的膝动脉栓塞中,以大口径导管起始操作对血管解剖不复杂的患者可能经济、安全且有利,可显著缩短手术和透视时间从而减少辐射暴露;血管路径复杂者改用微导管可提高操作成功率。
研究设计与样本
- 回顾性分析纳入79例因膝骨关节炎行膝动脉栓塞的患者,按使用微导管经大口径导管或直接经大口径导管分组,评估操作成功、不良事件、手术时间、辐射暴露及1、3、6个月VAS和WOMAC评分。
诊断标准与关键数值
- 操作成功率:微导管组100%,大口径导管组91%(p=0.069)。
- 手术时间和透视时间在大口径导管组显著更短(p<0.001)。
- 大口径导管组空气比释动能值明显降低。
- 1、3、6个月VAS和WOMAC评分两组间无显著差异。
临床应用与阅片要点
- 作者认为,对血管解剖不复杂的患者,以大口径导管起始行膝动脉栓塞可能经济、安全且有利,可缩短手术和透视时间并减少辐射暴露。
- 作者认为,对血管路径复杂的患者,改用微导管可提高操作成功率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of this study was to evaluate the comparative effectiveness and safety of using macrocatheters versus microcatheters for genicular artery embolization (GAE) in the management of knee osteoarthritis (OA). The primary outcomes were technical success and adverse events during and immediately after the procedure. The secondary outcome was the clinical outcome over the follow-up period.
MATERIALS AND METHODS: In our retrospective analysis, we included 79 patients undergoing GAE for OA. Patients were categorized based on the catheter type used: microcatheter through macrocatheter or directly through macrocatheter. Key parameters, including technical success, adverse events, procedure duration, radiation exposure, and clinical outcomes (VAS and WOMAC scores), were assessed at 1st, 3rd, and 6th-month intervals.
RESULTS: Technical success stood at 100 % for the microcatheter group, with a slight reduction for the macrocatheter group at 91 % (p = 0.069). Procedure and fluoroscopy durations were significantly shorter in the macrocatheter group (p < 0.001). Additionally, the macrocatheter group demonstrated a marked reduction in radiation dose, with notably decreased air kerma values. Clinical outcomes, including VAS and WOMAC scores at the predefined intervals, revealed no significant disparities between the two cohorts.
CONCLUSION: In GAE procedures utilizing a temporary embolic agent (imipenem/cilastatin), initiating the intervention with a macrocatheter can be deemed cost-effective, safe and advantageous for patients with less complex vascular anatomy, as it significantly reduces procedural and fluoroscopy times, thereby minimizing radiation exposure. Conversely, in patients with intricate vascular pathways, transitioning to a microcatheter enhances technical success.
引用
- Guzelbey T, Dablan A, Arslan MF, et al. Comparing technical success and clinical outcomes of macrocatheter versus microcatheter in genicular artery embolization for knee osteoarthritis. Eur J Radiol. 2024. PMID: 38897050. doi:10.1016/j.ejrad.2024.111582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。